Centessa Pharmaceuticals (CNTA) Change in Acquisitions & Divestments (2023 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Change in Acquisitions & Divestments for 3 consecutive years, with $95.6 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 282.36% to $95.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $321.6 million through Dec 2025, up 87.16% year-over-year, with the annual reading at $321.6 million for FY2025, 87.16% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $95.6 million at Centessa Pharmaceuticals, down from $107.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $107.7 million in Q3 2025, with the low at $25.0 million in Q4 2024.
  • Average Change in Acquisitions & Divestments over 3 years is $63.2 million, with a median of $58.5 million recorded in 2023.
  • The sharpest move saw Change in Acquisitions & Divestments crashed 51.76% in 2024, then surged 282.36% in 2025.
  • Over 3 years, Change in Acquisitions & Divestments stood at $51.8 million in 2023, then plummeted by 51.76% to $25.0 million in 2024, then soared by 282.36% to $95.6 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $95.6 million, $107.7 million, and $43.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.